US equities
|
NVDA
$239.96
▲+2.57%
SPCX
$169.77
▲+6.80%
MU
$1,063.65
▼-1.05%
TSLA
$379.71
▲+2.46%
SNDK
$1,706.49
▼-0.78%
MSFT
$528.83
▲+2.18%
INTC
$116.18
▼-2.64%
META
$743.07
▲+2.06%
NVDA
$239.96
▲+2.57%
SPCX
$169.77
▲+6.80%
MU
$1,063.65
▼-1.05%
TSLA
$379.71
▲+2.46%
SNDK
$1,706.49
▼-0.78%
MSFT
$528.83
▲+2.18%
INTC
$116.18
▼-2.64%
META
$743.07
▲+2.06%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Angelini Pharma
Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals
July 16, 2026
From
Angelini Pharma
Via
GlobeNewswire
Tickers
CPRX
Angelini Pharma Announces Appointment of Sergio Marullo di Condojanni as New CEO
January 21, 2026
From
Angelini Pharma
Via
GlobeNewswire
Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset
September 22, 2025
From
Angelini Pharma
Via
GlobeNewswire
Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset
October 21, 2024
From
Angelini Pharma
Via
GlobeNewswire
Angelini Pharma Appoints Rafal Kaminski as New Chief Scientific Officer
January 13, 2022
From
Angelini Pharma
Via
Business Wire
